Drawing for CLOFARA

USPTO serial 76434614

CLOFARA

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
DALIER, JOHN DAVID
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CLOFARA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Laura A. Coruzzi

LAURA A CORUZZI PENNIE & EDMONDS LLP1155 AVE OF THE AMERICASNEW YORK, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005PHARMACEUTICALS, NAMELY THERAPEUTIC DRUGS ADMINISTERED IN THE TREATMENT OF CANCER AND AUTOIMMUNE DISEASESACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 9, 2003MAILPAPER RECEIVED—
Jun 6, 2003ABN1ABANDONMENT - EXPRESS MAILED—
Apr 1, 2003NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 7, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 18, 2002NPUBNOTICE OF PUBLICATION—
Oct 28, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 24, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance